Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity

Journal of Dermatology

Volumn 34, Issue 7, 2007, Pages 419-429

  Yamamoto, Aisaku ^a   Watanabe, Hideaki ^a   Sueki, Hirohiko ^a   Nakanishi, Takako ^a   Yasuhara, Hajime ^a   Iijima, Masafumi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Langerhans cell migration; PTK787 ZK 222584; Skin draining lymph nodes; VEGF; VEGF receptors 1 and 2

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VATALANIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTACT ALLERGY; CONTROLLED STUDY; EAR; EPIDERMIS; FEMALE; FLOW CYTOMETRY; IMMUNOASSAY; IMMUNOPATHOGENESIS; LANGERHANS CELL; LYMPH NODE; MOUSE; NONHUMAN; SENSITIZATION; SWELLING;

ANIMALS; ANTIGENS, CD; CELL MIGRATION INHIBITION; DERMATITIS, ALLERGIC CONTACT; DERMIS; EAR, EXTERNAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; LANGERHANS CELLS; LASER-DOPPLER FLOWMETRY; LYMPH NODES; MICE; MICE, INBRED BALB C; OXAZOLONE; PHTHALAZINES; PROTEIN KINASE INHIBITORS; PYRIDINES; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 34250781070     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00304.x     Document Type: Article

References (52)

1. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J immunol 1990 144 : 4121 4128.
2. Xu H, Dilulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 1996 183 : 1001 1012.
3. Hauser C. The interaction between Langerhans cells and CD4+ T cells. J Dermatol 1992 19 : 722 725.
4. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002 22 : 407 412.
5. Akiba H, Kehren J, Ducluzeau MT et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 2002 168 : 3079 3087.
6. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 1987 166 : 1654 1667.
7. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990 145 : 2833 2838.
8. Cumberbatch M, Dearman RJ, Griffiths CE, Groves RW, Kimber I. In : Cavani A (ed.) Immune Mechanisms of Allergic Contact Dermatitis. Austin : Landes Bioscience, 2000 1508.
9. Gunnes G, Jorundsson E, Press CM, Landsverk T. Accessory cell populations in draining lymph nodes of lambs in the elicitation phase of DNCB-induced contact hypersensitivity. Vet Immunol Immunopathol 2000 76 : 75 88.
10. Wood JM. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy. Medicina 2000 60 (Suppl 2 41 47.
11. Brown LF, Detmar M, Claffey K et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. EXS 1997 79 : 233 269.
12. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998 140 : 947 959.
13. Jakeman LB, Winer J, Bennett GL, Altar CA, Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 1992 89 : 244 253.
14. Parry TJ, Cushman C, Gallegos AM et al. Bioactivity of anti-angiogenic ribozymes targeting Flt-1 and KDR mRNA. Nucleic Acids Res 1999 27 : 2569 2577.
15. Brown LF, Olbricht SM, Berse B et al. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. J Immunol 1995 154 : 2801 2807.
16. Watanabe H, Mamelak AJ, Wang B et al. Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity. Exp Dermatol 2004 13 : 671 681.
17. Kunstfeld R, Hirakawa S, Hong YK et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 2004 104 : 1048 1057.
18. Ozaki H, Seo MS, Ozaki K et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 2000 156 : 697 707.
19. Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000 41 : 3158 3164.
20. Wood JM, Bold G, Buchdunger E et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 2000 60 : 2178 2189.
21. Galli SJ, Hammel I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 1984 226 : 710 713.
22. Kondo S, Wang B, Fujisawa H et al. Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J Immunol 1995 155 : 3801 3805.
23. Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 1995 105 : 749 755.
24. Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002 62 : 1996 2003.
25. Vremec D, Zorbas M, Scollay R et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med 1992 176 : 47 58.
26. Cumberbatch M, Dearman RJ, Kimber D. Influence of ageing on Langerhans cell migration in mice. identification of a putative deficiency of epidermal interleukin-1β. Immunology 2002 105 : 466 477.
27. Wang B, Fujisawa H, Zhuang L et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997 159 : 6148 6155.
28. Waxman K, Lefcourt N, Achauer B. Heated laser Doppler flow measurements to determine depth of burn injury. Am J Surg 1989 157 : 541 543.
29. Brcic A, Zdravic F. Lessons learnt from 2,409 burn patients operated by early excision. Scand J Plast Reconstr Surg 1979 13 : 107 109.
30. Rendl M, Mayer C, Weninger W, Tschachler E. Topically applied lactic acid increases spontaneous secretion of vascular endothelial growth factor by human reconstructed epidermis. Br J Dermatol 2001 145 : 3 9.
31. Shibata M, Sueki H, Suzuki H et al. Impaired contact hypersensitivity reaction and reduced production of vascular endothelial growth factor in tumor necrosis factor-alpha gene-deficient mice. J Dermatol 2005 32 : 523 533.
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-Phenol reagents. J Biol Chem 1951 193 : 265 275.
33. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971 285 : 1182 1186.
34. Drevs J, Muller-Driver R, Wittig C et al. PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res 2002 62 : 4015 4022.
35. Mross K, Drevs J, Muller M et al. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours. Eur J Cancer 2005 41 : 1291 1299.
36. Lange-Asschenfeldt B, Weninger W, Velasco P et al. Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 2002 99 : 538 545.
37. Staquet MJ, Godefroy S, Jacquet C, Viac J, Schmitt D. Vascular endothelial growth factor (VEGF) induces human Langerhans cell migration. Arch Dermatol Res 2001 293 : 26 28.
38. Noirey N, Staquet MJ, Garaiazzo MJ et al. Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. Eur J Cell Biol 2002 81 : 383 389.
39. Matsumoto T, Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001 112 : RE21.
40. Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997 57 : 765 772.
41. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 1996 59 : 100 115.
42. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999 13 : 9 22.
43. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J Dermatol Sci 2000 24 (Suppl 1 S78 84.
44. Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 2003 101 : 560 567.
45. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D : Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996 87 : 3336 3343.
46. Luttun A, Tjwa M, Moons L et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002 8 : 831 840.
47. Detmar M, Brown LF, Schon MP et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998 111 : 1 6.
48. Risau W. Angiogenesis and endothelial cell function. Arzneimittelforschung 1994 44 : 416 417.
49. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000 6 : 389 95.
50. Belsito DV. Allergic contact dermatitis. In : Freedberg IM, Eisen AZ, Wolff K et al. (eds). Fitzpatrick's Dermatology in General Medicine, 5th edn. New York : McGraw-Hill, 2001 : 1447 1461.
51. Cohen LM, Skopicki DK, Harrist TJ, Clark WH. Noninfectious Vesiculobullous and Vesiculopustular Diseases. In : Elder D, Elenitsas R, Jaworsky C, Johnson B (eds). Liver's Histopathology of the Skin, 8th edn. Philadelphia : Lippincott-Raven Publishers, 1997 : 209.
52. Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J. IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 2002 11 : 224 231.